Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1974;43:893-895
© 1974 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SWATE, T. E.
Right arrow Articles by WEED, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SWATE, T. E.
Right arrow Articles by WEED, J. C.

Boric Acid Treatment of Vulvovaginal Candidiasis

TOMMY E. SWATE, MD and JOHN C. WEED, MD, FACOG

Department of Obstetrics and Gynecology, Ochsner Clinic and Ochsner Foundation Hospital, New Orleans, Louisiana.

After in vitro tests indicated that boric acid is fungistatic against Candida albicans, it was used to treat vulvovaginal candidiasis, with symptomatic relief in all 40 patients. None of the tested patients had detectable levels of boric acid in the seurm. Thirty-eight of the 40 patients had no recurrence of symptoms 30 days after therapy. Boric acid therapy for vulvovaginal candidiasis was found to be safe, effective, and inexpensive.




This article has been cited by other articles:


Home page
 Int. J. Syst. Evol. Microbiol.Home page
H. Miwa, I. Ahmed, J. Yoon, A. Yokota, and T. Fujiwara
Variovorax boronicumulans sp. nov., a boron-accumulating bacterium isolated from soil
Int J Syst Evol Microbiol, January 1, 2008; 58(1): 286 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Int. J. Syst. Evol. Microbiol.Home page
I. Ahmed, A. Yokota, and T. Fujiwara
Gracilibacillus boraciitolerans sp. nov., a highly boron-tolerant and moderately halotolerant bacterium isolated from soil
Int J Syst Evol Microbiol, April 1, 2007; 57(4): 796 - 802.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Ray, R. Goswami, U. Banerjee, V. Dadhwal, D. Goswami, P. Mandal, V. Sreenivas, and N. Kochupillai
Prevalence of Candida glabrata and Its Response to Boric Acid Vaginal Suppositories in Comparison With Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis
Diabetes Care, February 1, 2007; 30(2): 312 - 317.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. S. Richter, R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller
Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases
J. Clin. Microbiol., May 1, 2005; 43(5): 2155 - 2162.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Animal Hospital AssociationHome page
C. L. Mendelsohn, C. E. Griffin, W. S. Rosenkrantz, L. D. Brown, and M. J. Boord
Efficacy of Boric-Complexed Zinc and Acetic-Complexed Zinc Otic Preparations for Canine Yeast Otitis Externa
J. Am. Anim. Hosp. Assoc., January 1, 2005; 41(1): 12 - 21.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Obstetricians and Gynecologists.